ADM adds bioconverted Reb M stevia line to SweetRight platform

ADM has expanded its SweetRight sweetener range with SweetRight Stevia Echo, a bioconverted stevia line that includes SweetRight Stevia Echo M and SweetRight Echo RM 95. The company says Echo RM 95 is the highest-purity Reb M product on its platform.

The launch lands in a crowded ingredient category. Cargill, Tate & Lyle and Ingredion all sell their own next-generation stevia lines, and ADM itself has prior partnerships with GLG Life Tech on Reb M production.

What bioconversion does for the economics

Reb M is the steviol glycoside food formulators want most: the cleanest sugar-like profile with the least bitter aftertaste of the major stevia compounds. The problem is that Reb M occurs in the stevia leaf in vanishingly small quantities, which makes leaf-extraction uneconomic at the purity levels reformulators need for mainstream beverages and dairy.

Bioconversion sidesteps the leaf bottleneck. Producers start with a more abundant glycoside (typically Reb A or stevioside) and use enzymes to convert it into Reb M. The output is identical to what's in the leaf; the unit economics are not. This is the same production logic Cargill's EverSweet and Tate & Lyle's expanded stevia portfolio lean on.

ADM has not disclosed pricing or capacity for the Echo line, and the announcement does not specify which substrate the bioconversion starts from.

Where this fits in the reformulation cycle

The stevia category has been moving in one direction since 2022: away from blends that rely heavily on Reb A (cheaper, more bitter) and toward Reb D and Reb M (cleaner taste, historically much more expensive). The barrier was always cost. Bioconversion at scale is what closes the gap.

For CPG formulators, the pitch is straightforward. Sugar reduction targets are now embedded in nearly every multinational's public commitments, and GLP-1 receptor agonists have shifted some calorie-conscious volume but not removed the underlying reformulation pressure. Higher-purity Reb M lets reformulators replace more sugar without triggering the aftertaste complaints that killed earlier stevia-sweetened launches.

What to watch

Three things will tell you whether this matters beyond press-release noise. First, capacity disclosures: ADM has not said how much Echo RM 95 it can produce, which is the only number that determines whether it's a real commercial product or a sampling program. Second, named customer wins: bioconverted Reb M only matters when a tier-one beverage or dairy customer reformulates onto it. Third, the price curve: industry trade data over the next two to three quarters will show whether bioconversion is finally pulling Reb M's bulk price down toward Reb A territory, which is the inflection point reformulators are waiting for.